Development of purified glycogen derivatives as siRNA nanovectors
Giuseppe Francesco Racaniello(Tio University), Nunzio Denora(University of Bari Aldo Moro), Juliette Vergnaud(Université Paris-Saclay), Valentino Laquintana(University of Bari Aldo Moro), Francesco Leonetti(University of Bari Aldo Moro), Paola Pontrelli(University of Bari Aldo Moro), Annalisa Cutrignelli(University of Bari Aldo Moro), Antonio Lopalco(University of Bari Aldo Moro), Elias Fattal(Université Paris-Sud), Mauro Fiume(University of Bari Aldo Moro), Loreto Gesualdo(University of Bari Aldo Moro), Massimo Franco(University of Bari Aldo Moro), Angela Lopedota(University of Bari Aldo Moro)
Cited by 8
Related Papers
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
|The Lancet|2023|264
Thiolated polymeric hydrogels for biomedical application: Cross-linking mechanisms
|Journal of Controlled Release|2020|208
Thiolated Nanoparticles for Biomedical Applications: Mimicking the Workhorses of Our Body
|Advanced Science|2021|101
Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma
|International Journal of Molecular Sciences|2023|98